Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
Detailed Information | |
---|---|
Biomarker ID | 1528 |
PMID | 25174820 |
Year | 2014 |
Biomarker | Death Receptor 5 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Tissue |
Subjects | Humans |
Regulation | Downregulated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathway include: Dimerization of procaspase-8; Apoptosis Modulation and Signaling; PEDF Induced Signaling; DNA Damage Response; TNFR1 Pathway |
Experiment | High Grade cancer Vs Low grade Cancer |
Type of Biomarker | Prognostic |
Cohort | The 54 cases of PCa were classified according to the Gleason score as follows: 27 lowâ€grade prostatic carcinoma [Gleason score 2â€5 (LG PCa)] and 27 highâ€grade prostatic carcinoma [Gleason score 6â€10 (HG PCa)] |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | P<0.0001 |
Method Used | Immunohistochemistry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |